- Home
- SWIN vs OCX Comparison
SWIN vs OCX Comparison
Compare SWIN & OCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- OCX
- Stock Information
- Founded
- SWIN 2017
- OCX 2009
- Country
- SWIN Hong Kong
- OCX United States
- Employees
- SWIN N/A
- OCX N/A
- Industry
- SWIN
- OCX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- SWIN
- OCX Health Care
- Exchange
- SWIN Nasdaq
- OCX Nasdaq
- Market Cap
- SWIN 41.7M
- OCX 38.7M
- IPO Year
- SWIN 2023
- OCX N/A
- Fundamental
- Price
- SWIN $2.50
- OCX $2.67
- Analyst Decision
- SWIN
- OCX Buy
- Analyst Count
- SWIN 0
- OCX 3
- Target Price
- SWIN N/A
- OCX $4.42
- AVG Volume (30 Days)
- SWIN 105.8K
- OCX 64.6K
- Earning Date
- SWIN 11-29-2024
- OCX 11-12-2024
- Dividend Yield
- SWIN N/A
- OCX N/A
- EPS Growth
- SWIN N/A
- OCX N/A
- EPS
- SWIN N/A
- OCX N/A
- Revenue
- SWIN $3,437,000.00
- OCX $709,000.00
- Revenue This Year
- SWIN N/A
- OCX N/A
- Revenue Next Year
- SWIN N/A
- OCX $167.93
- P/E Ratio
- SWIN N/A
- OCX N/A
- Revenue Growth
- SWIN N/A
- OCX N/A
- 52 Week Low
- SWIN $2.01
- OCX $2.29
- 52 Week High
- SWIN $72.55
- OCX $4.31
- Technical
- Relative Strength Index (RSI)
- SWIN 46.05
- OCX 45.50
- Support Level
- SWIN $2.15
- OCX $2.50
- Resistance Level
- SWIN $2.60
- OCX $3.04
- Average True Range (ATR)
- SWIN 0.23
- OCX 0.15
- MACD
- SWIN 0.00
- OCX -0.02
- Stochastic Oscillator
- SWIN 50.72
- OCX 55.56
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About OCX Oncocyte Corporation
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers.